Proliferation of the human urothelium is induced by atypical β1-adrenoceptors

M. Winder, C. Wasén, P. Aronsson, D. Giglio
{"title":"Proliferation of the human urothelium is induced by atypical β1-adrenoceptors","authors":"M. Winder,&nbsp;C. Wasén,&nbsp;P. Aronsson,&nbsp;D. Giglio","doi":"10.1111/aap.12036","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>\n \n </p><ol>\n \n \n <li>We wanted to assess whether β-adrenoceptors mediate proliferation in the normal and malignant urothelial cell lines UROtsa and T24, respectively.</li>\n \n \n <li>Urothelial cells were cultured for 24 h in the presence of the β-adrenoceptor agonists isoprenaline (β<sub>1/2/3</sub>), dobutamine (β<sub>1</sub>), salbutamol (β<sub>2</sub>), BRL 37344 (β<sub>3</sub>), CGP 12177 (a partial β-agonist) or β-adrenoceptor antagonists (metoprolol; β<sub>1</sub>, propranolol; β<sub>1/2</sub>). Phosphorylation of kinases was screened with a Human Phospho-Kinase Array Kit (R&amp;D systems). Intracellular pathways activated by proliferation of urothelial cells were characterized by incubating cells with the MEK1/2 inhibitor PD 98,059, the p38 kinase inhibitor losmapimod or with the Akt 1/2 kinase inhibitor. Proliferation was assessed with the MTT proliferation assay (ATCC). Western blot and immunocytochemistry were used for detection of the β<sub>1</sub>-adrenoceptor.</li>\n \n \n <li>Isoprenaline and dobutamine induced proliferation, while salbutamol and BRL 37344 did not. Dobutamine-induced proliferation was not affected by metoprolol or propranolol but was instead antagonized by CGP 12177 in T24 but not in UROtsa. In response to stimulation with dobutamine, Akt1/2/3 was phosphorylated in UROtsa, while ERK1/2 and p38 were phosphorylated in T24. MEK1/2 inhibition blocked basal and dobutamine-induced proliferation in T24 but only basal proliferation in UROtsa. Losmapimod slightly inhibited basal proliferation in T24 but not dobutamine-induced proliferation. Akt 1/2 inhibitor blocked basal and dobutamine-induced proliferation in UROtsa. Immunocytochemistry and Western blot revealed expression of β<sub>1</sub>-adrenoceptors in both urothelial cell lines.</li>\n \n \n <li>The present data show that the urothelium expresses atypical β1-adrenoceptors that activate intracellular kinases inducing urothelial proliferation.</li>\n </ol>\n \n </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/aap.12036","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autonomic and Autacoid Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/aap.12036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

  1. We wanted to assess whether β-adrenoceptors mediate proliferation in the normal and malignant urothelial cell lines UROtsa and T24, respectively.
  2. Urothelial cells were cultured for 24 h in the presence of the β-adrenoceptor agonists isoprenaline (β1/2/3), dobutamine (β1), salbutamol (β2), BRL 37344 (β3), CGP 12177 (a partial β-agonist) or β-adrenoceptor antagonists (metoprolol; β1, propranolol; β1/2). Phosphorylation of kinases was screened with a Human Phospho-Kinase Array Kit (R&D systems). Intracellular pathways activated by proliferation of urothelial cells were characterized by incubating cells with the MEK1/2 inhibitor PD 98,059, the p38 kinase inhibitor losmapimod or with the Akt 1/2 kinase inhibitor. Proliferation was assessed with the MTT proliferation assay (ATCC). Western blot and immunocytochemistry were used for detection of the β1-adrenoceptor.
  3. Isoprenaline and dobutamine induced proliferation, while salbutamol and BRL 37344 did not. Dobutamine-induced proliferation was not affected by metoprolol or propranolol but was instead antagonized by CGP 12177 in T24 but not in UROtsa. In response to stimulation with dobutamine, Akt1/2/3 was phosphorylated in UROtsa, while ERK1/2 and p38 were phosphorylated in T24. MEK1/2 inhibition blocked basal and dobutamine-induced proliferation in T24 but only basal proliferation in UROtsa. Losmapimod slightly inhibited basal proliferation in T24 but not dobutamine-induced proliferation. Akt 1/2 inhibitor blocked basal and dobutamine-induced proliferation in UROtsa. Immunocytochemistry and Western blot revealed expression of β1-adrenoceptors in both urothelial cell lines.
  4. The present data show that the urothelium expresses atypical β1-adrenoceptors that activate intracellular kinases inducing urothelial proliferation.
非典型β1-肾上腺素受体可诱导人尿路上皮的增殖
我们想要评估β-肾上腺素受体是否分别介导正常和恶性尿路上皮细胞系UROtsa和T24的增殖。尿路上皮细胞在β-肾上腺素受体激动剂异丙肾上腺素(β1/2/3)、多巴酚丁胺(β1)、沙丁胺醇(β2)、BRL 37344 (β3)、CGP 12177(部分β激动剂)或β-肾上腺素受体拮抗剂(美托洛尔;β1、普萘洛尔;β1/2)。使用Human Phospho-Kinase Array Kit (R&D systems)筛选激酶的磷酸化。通过MEK1/2抑制剂PD 98059、p38激酶抑制剂losmapimod或Akt 1/2激酶抑制剂孵育细胞,研究了尿路上皮细胞增殖激活的细胞内通路。用MTT增殖试验(ATCC)评估增殖情况。Western blot和免疫细胞化学检测β1-肾上腺素能受体。异丙肾上腺素和多巴酚丁胺可诱导细胞增殖,而沙丁胺醇和BRL 37344则无此作用。美托洛尔和心得安对多巴酚丁胺诱导的增殖没有影响,而CGP 12177对T24有拮抗作用,而对UROtsa无拮抗作用。多巴酚丁胺刺激后,UROtsa中Akt1/2/3被磷酸化,而T24中ERK1/2和p38被磷酸化。MEK1/2抑制可阻断T24细胞基底细胞和多巴酚丁胺诱导的增殖,但仅阻断UROtsa细胞基底细胞的增殖。Losmapimod对T24的基底细胞增殖有轻微抑制作用,但对多巴酚丁胺诱导的增殖没有抑制作用。Akt 1/2抑制剂阻断基底和多巴酚丁胺诱导的UROtsa细胞增殖。免疫细胞化学和Western blot显示两种尿路上皮细胞系均表达β1-肾上腺素受体。目前的数据表明,尿路上皮表达非典型β1-肾上腺素受体,激活细胞内激酶,诱导尿路上皮增殖。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信